Abstract
Aspartate transcarbamylase initiates the de novo biosynthetic pathway for the production of the pyrimidine nucleotides, precursors of nucleic acids. This pathway is particularly active in rapidly growing cells and tissues. Thus, this enzyme has been tested as a potential target for antiproliferative drugs. In the present work, on the basis of its structural and mechanistic properties, a series of substrate analogues, including potential suicide-pseudosubstrates was synthesized and their putative inhibitory effects were tested using E. coli aspartate transcarbamylase as a model. Two of these compounds appear to be very efficient inhibitors of this enzyme. © 2004 Published by Elsevier SAS.
Author supplied keywords
Cite
CITATION STYLE
Grison, C., Coutrot, P., Comoy, C., Balas, L., Joliez, S., Lavecchia, G., … Hervé, G. (2004). Design, synthesis and activity of bisubstrate, transition-state analogues and competitive inhibitors of aspartate transcarbamylase. European Journal of Medicinal Chemistry, 39(4), 333–344. https://doi.org/10.1016/j.ejmech.2004.01.006
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.